-
Autor
Akikusa, Jonathan D 1 Anton, Jordi 1 Avcin, Tadej 1 Bukowski, Jack 1 Burgos-Vargas, Ruben 1 Calvo Penades, Inmaculada 1 Chaitow, Jeffrey 1 Constantin, Tamas 1 Flato, Berit 1 Foeldvari, Ivan 1 Gamir, Maria Luz 1 Horneff, Gerd 1 Huppertz, Hans-Iko 1 Jaller Raad, Juan Jose 1 Jarosova, Katerina 1 Koskova, Elena 1 Lauwerys, Bernard R 1 Macku, Marie 1 Martini, Alberto 1 Nikishina, Irina 1
-
Pracoviště
1 Calvo Penades MD PhD Hospital Universitari... 1 1 Foeldvari MD Hamburg Centre for Child and ... 1 1 Nikishina MD 5 A Nasonova Research Institu... 1 B Flato MD PhD Oslo University Hospital Depa... 1 B R Lauwerys MD PhD Institut de Recherche Ex... 1 E Koskova MD PhD National Institute of Rheum... 1 From the Paediatric Rheumatology Internation... 1 G Horneff MD Asklepios Clinic Sankt Augustin... 1 H 1 Huppertz MD Klinikum Bremen Mitte Prof H... 1 J Anton MD PhD Pediatric Rheumatology Unit H... 1 J Chaitow MD The Sydney Children's Hospital ... 1 J D Akikusa MD Royal Children's Hospital Mel... 1 J J Raad MD Centro de Reumatologia y Ortoped... 1 J Vojinovic MD PhD Clinic of Pediatrics Clin... 1 K Jarosova MD Revmatologicky Ustav Prague Cz... 1 M L Gamir MD Hospital Ramon y Cajal Unidad d... 1 M Macku MD Fakultni nemocnice Brno Bohunice ... 1 R Burgos Vargas MD Hospital General de Mexic... 1 T Avcin MD PhD University Medical Centre Lju... 1 W J O 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Vlastník
-
Constantin, Tamas
Autor Constantin, Tamas From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Foeldvari, Ivan
Autor Foeldvari, Ivan From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Vojinovic, Jelena
Autor Vojinovic, Jelena From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Horneff, Gerd
Autor Horneff, Gerd From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Burgos-Vargas, Ruben
Autor Burgos-Vargas, Ruben From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Nikishina, Irina
Autor Nikishina, Irina From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Akikusa, Jonathan D
Autor Akikusa, Jonathan D From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Avcin, Tadej
Autor Avcin, Tadej From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Chaitow, Jeffrey
Autor Chaitow, Jeffrey From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
-
Koskova, Elena
Autor Koskova, Elena From the Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto G. Gaslini, Pediatria II-Reumatologia, PRINTO, Genoa, Italy.T. Constantin, MD, PhD, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary I. Foeldvari, MD, Hamburg Centre for Child and Adolescent Rheumatology, Hamburg, Germany J. Vojinovic, MD, PhD, Clinic of Pediatrics, Clinical Centre, Faculty of Medicine, University of Nis, Serbia G. Horneff, MD, Asklepios Clinic, Sankt Augustin, Germany R. Burgos-Vargas, MD, Hospital General de Mexico, Mexico City, Mexico I. Nikishina, MD, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia J.D. Akikusa, MD, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia T. Avcin, MD, PhD, University Medical Centre Ljubljana, Pediatric Clinic, Ljubljana, Slovenia J. Chaitow, MD, The Sydney Children's Hospital Network, Westmead, Sydney, Australia E. Koskova, MD, PhD, National Institute of Rheumatic Diseases, Piestany, Slovakia B.R. Lauwerys, MD, PhD, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium I. Calvo Penades, MD, PhD, Hospital Universitario y Politécnico La Fe, Pediatric Rheumatology Unit, Valencia, Spain B. Flato, MD, PhD, Oslo University Hospital, Department of Rheumatology, Oslo, Norway M.L. Gamir, MD, Hospital Ramon y Cajal Unidad de Reumatologia Pediatrica, Madrid, Spain H.I. Huppertz, MD, Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany J.J. Raad, MD, Centro de Reumatologia y Ortopedia, Barranquilla, Atlantico, Colombia K. Jarosova, MD, Revmatologicky Ustav, Prague, Czech Republic J. Anton, MD, PhD, Pediatric Rheumatology Unit, Hospital Sant Joan de Déu, Universitat de Barcelona, Espluges (Barcelona), Spain M. Macku, MD, Fakultni nemocnice Brno, Bohunice, Detska Nemocnice, Ambulance detske revmatologie detske kliniky, Brno, Czech Republic W.J. O
PubMed
26932344
DOI
10.3899/jrheum.150430
Knihovny.cz E-zdroje
OBJECTIVE: The main objective was to determine the 2-year clinical benefit and safety of etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended oligoarthritis (eoJIA), enthesitis-related arthritis (ERA), or psoriatic arthritis (PsA). METHODS: CLIPPER was a 96-week, phase IIIb, open-label, multicenter study. Patients with eoJIA, ERA, or PsA received ETN 0.8 mg/kg once weekly (50 mg max) for up to 96 weeks. The proportions of patients reaching the JIA American College of Rheumatology (ACR) 30/50/70/90/100 and inactive disease responses at Week 96 were calculated. Adverse events (AE) were collected throughout the study (intention-to-treat sample). RESULTS: There were 127 patients (eoJIA n = 60, ERA n = 38, PsA n = 29) who received ≥ 1 dose of ETN. The mean disease duration was 31.6 (eoJIA), 23.0 (ERA), and 21.8 (PsA) months. At Week 96, JIA ACR 30/50/70/90/100/inactive disease responses (95% CI) were achieved by 84.3% (76.7, 90.1), 83.5% (75.8, 89.5), 78.7% (70.6, 85.5), 55.1% (46.0, 63.9), 45.7% (36.8, 54.7), and 27.6% (20.0, 36.2) of patients, respectively. The most common AE (no. events, events per 100 patient-yrs) overall were headache (23, 10.7), pyrexia (12, 5.6), and diarrhea (10, 4.6). The most common infections were upper respiratory tract infection (83, 38.6), pharyngitis (50, 23.2), gastroenteritis (22, 10.2), bronchitis (19, 8.8), and rhinitis (17, 7.9). No cases of malignancy, active tuberculosis, demyelinating disorders, or death were reported. CONCLUSION: Over 96 weeks of therapy, ETN demonstrated sustained efficacy at treating the clinical symptoms of all 3 JIA categories, with no major safety issues.
- MeSH
- antirevmatika škodlivé účinky terapeutické užití MeSH
- dítě MeSH
- etanercept škodlivé účinky terapeutické užití MeSH
- juvenilní artritida farmakoterapie MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- psoriatická artritida farmakoterapie MeSH
- výsledek terapie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky, fáze II MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.